Skip to main content

Table 1 RBM5 expression was correlated with clinicopathological characteristics of gliomas

From: RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis

Characteristics Total RBM5 expression P value
Low High
All cases 51 28 23  
Age (year)     0.068
 <60 22 13 9  
 ≥60 29 15 14  
Grade 21 9 12 0.148
 G1/G2 21 9 12  
 G3/G4 30 19 11  
TNM stage     0.004
 Early (I/II) 23 8 17  
 Late (III/IV) 28 20 8  
Sex     0.405
 Male 32 19 13  
 Female 19 9 10